Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Study ID
NCT02625610

Study type
Interventional

Study phase
Phase 3

Study status
Completed

Trial Acronym

Trial Summary

The purpose of this study was to demonstrate superiority of treatment with avelumab versus continuation of first-line chemotherapy.

More informations

Trial Starting Date

Dec 24,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

499